Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.

Xia Y, Yu PB, Sidis Y, Beppu H, Bloch KD, Schneyer AL, Lin HY.

J Biol Chem. 2007 Jun 22;282(25):18129-40. Epub 2007 May 1.

2.
3.

Bone morphogenetic proteins.

Chen D, Zhao M, Mundy GR.

Growth Factors. 2004 Dec;22(4):233-41. Review.

PMID:
15621726
4.

Repulsive guidance molecule (RGM) family proteins exhibit differential binding kinetics for bone morphogenetic proteins (BMPs).

Wu Q, Sun CC, Lin HY, Babitt JL.

PLoS One. 2012;7(9):e46307. doi: 10.1371/journal.pone.0046307. Epub 2012 Sep 27.

5.

Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.

Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, Campagna JA, Schneyer AL, Woolf CJ, Lin HY.

J Biol Chem. 2005 Aug 19;280(33):29820-7. Epub 2005 Jun 23.

6.

Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.

Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY.

Blood. 2008 May 15;111(10):5195-204. doi: 10.1182/blood-2007-09-111567. Epub 2008 Mar 7.

7.

Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells.

Yu PB, Deng DY, Beppu H, Hong CC, Lai C, Hoyng SA, Kawai N, Bloch KD.

J Biol Chem. 2008 Feb 15;283(7):3877-88. Epub 2007 Nov 27.

8.

DRAGON, a bone morphogenetic protein co-receptor.

Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L, Woolf CJ.

J Biol Chem. 2005 Apr 8;280(14):14122-9. Epub 2005 Jan 25.

9.

Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle.

Kayani AR, Glister C, Knight PG.

Reproduction. 2009 Jan;137(1):67-78. doi: 10.1530/REP-08-0198. Epub 2008 Oct 20.

10.

Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.

Fatehi AN, van den Hurk R, Colenbrander B, Daemen AJ, van Tol HT, Monteiro RM, Roelen BA, Bevers MM.

Theriogenology. 2005 Feb;63(3):872-89.

PMID:
15629804
11.

BMP2, BMP4, noggin, BMPRIA, BMPRIB, and BMPRII are differentially expressed in the adult rat spinal cord.

Miyagi M, Mikawa S, Sato T, Hasegawa T, Kobayashi S, Matsuyama Y, Sato K.

Neuroscience. 2012 Feb 17;203:12-26. doi: 10.1016/j.neuroscience.2011.12.022. Epub 2011 Dec 20.

PMID:
22202460
12.

Neogenin-RGMa signaling at the growth cone is bone morphogenetic protein-independent and involves RhoA, ROCK, and PKC.

Conrad S, Genth H, Hofmann F, Just I, Skutella T.

J Biol Chem. 2007 Jun 1;282(22):16423-33. Epub 2007 Mar 27. Erratum in: J Biol Chem. 2010 Dec 31;285(53):42140.

13.

Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.

Upton PD, Davies RJ, Tajsic T, Morrell NW.

Am J Respir Cell Mol Biol. 2013 Dec;49(6):1135-45. doi: 10.1165/rcmb.2012-0470OC.

15.

A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor.

Chan MC, Nguyen PH, Davis BN, Ohoka N, Hayashi H, Du K, Lagna G, Hata A.

Mol Cell Biol. 2007 Aug;27(16):5776-89. Epub 2007 Jun 18.

16.

Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY.

Nat Genet. 2006 May;38(5):531-9. Epub 2006 Apr 9.

PMID:
16604073
17.

Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.

Kudo TA, Kanetaka H, Watanabe A, Okumoto A, Asano M, Zhang Y, Zhao F, Kano M, Shimizu Y, Tamura S, Hayashi H.

Tohoku J Exp Med. 2010 Oct;222(2):121-9.

18.

Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.

Yang J, Davies RJ, Southwood M, Long L, Yang X, Sobolewski A, Upton PD, Trembath RC, Morrell NW.

Circ Res. 2008 May 23;102(10):1212-21. doi: 10.1161/CIRCRESAHA.108.173567. Epub 2008 Apr 24.

19.

Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.

Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim DK, Morrell NW.

Circulation. 2009 Feb 3;119(4):566-76. doi: 10.1161/CIRCULATIONAHA.108.821504. Epub 2009 Jan 19.

20.

Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.

Li J, Ye L, Kynaston HG, Jiang WG.

Int J Oncol. 2012 Feb;40(2):544-50. doi: 10.3892/ijo.2011.1251. Epub 2011 Nov 4.

PMID:
22076499
Items per page

Supplemental Content

Write to the Help Desk